$CAPR

9.97 ▲ 12.39% Regular sessionas of 11:26:20am ET

Every Regards of Wallstreet article on $CAPR, newest first — 2 stories and counting.

My Market shows CAPR next to the other stocks you follow, with how each is moving today and its next earnings date. Free, no sign-up.

The current story

Updated· 27 min read

Capricor (CAPR) Narrows to Upper Limb, and the August 22 FDA Date Moves

The FDA extended Capricor's deramiocel PDUFA date from August 22 to November 22, a three-month major-amendment delay confirmed August 24, and CAPR traded up more than 7% intraday to $6.75 on the news.

  1. 2026-08-14 · 8 min read

    Why Capricor (CAPR) Rose 58%: The FDA Decision Went Away, and I Called It Wrong

    Capricor closed up 57.96% on August 14 after saying it will narrow the deramiocel label and let the FDA move the August 22 PDUFA date. Our preview read the trial data right and the trade wrong.

How has $CAPR traded after past reports? See its earnings history: beats, misses and the moves →

New to options? See our plain-English strategy playbook →

The Week-Ahead Brief

Don’t miss next week’s setups. Get the Sunday brief.

Every Sunday: next week’s earnings dates, Fed days and the trades worth watching, from the same desk that writes the week-ahead hub. Free, built for retail investors.

Subscribing means we email you the newsletter and nothing else. No spam, no sharing your address, unsubscribe in one click. See the privacy policy.